Navigation Links
ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
Date:3/18/2009

for the new draft guidance expires on March 19, 2009. OGD has acknowledged the complexity of the issues involved, and specifically stated that the Agency will carefully consider all comments before responding to ViroPharma's Citizen Petition and finalizing BE recommendations for Vancocin.

"While we appreciate that the FDA has provided a limited level of public process, we continue to vehemently disagree with an approach that we believe places patient lives in the hands of an unproven method that is riddled with assumptions, and the result of a profoundly flawed process which could lead to sub-therapeutic versions of Vancocin," said Thomas Doyle, ViroPharma's vice president of strategic initiatives. "We reiterate our willingness to assist FDA in any way we can in the development of a rigorous method that will ensure the approval of safe and effective generic versions of Vancocin. We note in our comments that will we share the data from the ongoing study we are sponsoring at Temple University regarding the GI conditions to be found in patients with CDI, preliminary data from which indicate that CDI patients do not exhibit the healthy GI physiology asserted by OGD. We are also willing to provide FDA with unrestricted financial support for efforts aimed at developing a scientifically rigorous bioequivalence method for generic copies of Vancocin."

Some of the many points of concern over the draft BE Guidelines described in ViroPharma's submission include:

  • The December 2008 Draft Guidance method is not correlated with patient outcomes, as the law and good science require.
  • Documented examples repeatedly demonstrate OGD's poor judgment and bad faith in developing bioequivalence methods for Vancocin.
  • OGD has gone to great lengths to avoid any consideration of the actual environment in which Vancocin will be used - patients with infected GI tracts - t
    '/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
2. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
3. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
4. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
7. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
8. ViroPharma to Present at the Natixis Bleichroeder Conference
9. ViroPharma to Present at Three Upcoming Healthcare Conferences
10. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
11. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  Results of the ... Consecutive Cases Using MarginProbe for Intra-Operative Positive Margin Detection ... session at the 32 nd Annual Miami Breast ... conducted by Moshe Papa , MD, FACS, Professor ... Tel Aviv University, reports an analysis of MarginProbe,s efficiency ...
(Date:3/4/2015)... N.J. , March 4, 2015  Bayer ... Drug Administration (FDA) has accepted the company,s Biologics ... Factor VIII compound.  Bayer is seeking FDA approval ... for the treatment of hemophilia A in children ... to continually bringing new therapies to hemophilia A ...
(Date:3/4/2015)... March 4, 2015  Heska Corporation (Nasdaq: ... You to Join Its Fourth Quarter and Year End ... 2015 @ 9:00 a.m. (MST) / 11:00 a.m. (EST)Where: ... 2014 Earnings Call link on the front page of ... to the web at the address above.  Alternatively, you ...
Breaking Medicine Technology:New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2
... Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer ... the first fiscal quarter ended September 30, 2009, compared with ... of 2.2%. , The first quarter of fiscal 2010 produced ... $94,133 for the first quarter of fiscal 2009. The net ...
... 12 A new software technology is helping to ... by electronically identifying the sperm, eggs, resulting embryos and ... (IVF) treatment cycles. Using non-invasive Radio Frequency Identification (RFID), ... embryos during the course of treatment. If the wrong ...
Cached Medicine Technology:Corgenix Reports Financial Results for First Quarter of Fiscal 2010 2Corgenix Reports Financial Results for First Quarter of Fiscal 2010 3New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 2New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 3
(Date:3/4/2015)... and Dayton, Ohio (PRWEB) March 04, 2015 ... killed in an IED explosion in Iraq, tells you ... recovering. He received some free Chiropractic care from the ... Magnetic Resonance Therapy. , This is what Harris said ... the Magnesphere, I have clarity, I feel more calm, ...
(Date:3/4/2015)... CA (PRWEB) March 04, 2015 ... have been selected by Chase Brexton Health Care, ... announced today. , Chase Brexton provides comprehensive primary ... than 30,000 patients across seven clinics in the ... adopters of electronic medical records, the organization has ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... CNS therapeutics market is driven by the increasing incidence ... an encouraging pipeline of late stage drugs. The unmet ... to fore the untapped potential in the market. Presently, ... effective drugs that overcome the limitations of current generation ...
(Date:3/4/2015)... 04, 2015 Follow us on ... enhancing the appearance of the skin and body, are ... of therapeutic agents to achieve the desired product properties ... society obsessed with physical beauty, youth, and achievement. Demand ... and sales of cosmetics. Growth in the market is ...
(Date:3/4/2015)... Ada Products Company, Inc ., an ... strategic partnership with the Dental Exchange in an effort ... them to engaging, inspiring ideas, products, career opportunities, and ... Dental Exchange is a first-of-its kind online resource ... other social platforms, the Dental Exchange dives much deeper ...
Breaking Medicine News(10 mins):Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 2Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 3Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Ada Products Company, Inc. Announces Strategic Partnership with the Dental Exchange 2
... University of South Florida Department of Neurosurgery and Brain ... from the National Institutes of Health to investigate the ... benefit post-stroke patients by repairing the blood-brain barrier (BBB). ... entering the brain while allowing passage of needed substances. ...
... different alcoholic beverages and drinking behaviour on the risk of ... Cohort of Swedish Men, to study the association between consumption ... pancreatitis. In total, 84,601 individuals, aged 46-84 years, were ... developed acute pancreatitis. There was a doseresponse association between ...
... (HealthDay News) -- What do a prehistoric water reptile ... than you might expect, new research indicates. A ... its embryo offers the first evidence of live birth ... have had a social structure similar to modern dolphins, ...
... Electrodiagnostic Medicine (AANEM) has awarded accreditation status to four ... Neuromuscular Center in Northeast Ohio. The EMG labs ... Ahuja Medical Center in Beachwood, Oh., UH University Suburban ... Health Center in Westlake, Oh., received accreditation. UH Case ...
... isolating cells from patients, spinal tissue within a few days ... have developed a new model of the paralyzing disease amyotrophic ... cells called astrocytes become toxic to nerve cells a ... The new model could be used to investigate many ...
... , THURSDAY, Aug. 11 (HealthDay News) -- Symptoms ... people over 80, according to a new study that ... memory loss. The study included 105 Alzheimer,s patients ... age, those 60 to 75 (young-old) and those 80 ...
Cached Medicine News:Health News:USF researchers get $2.6 million NIH grant to investigate new post-stroke therapy 2Health News:Alcohol consumption in relation to acute pancreatitis 2Health News:Prehistoric Water Reptile's Social Life Similar to Dolphins: Study 2Health News:New model of ALS is based on human cells from autopsied tissue 2Health News:New model of ALS is based on human cells from autopsied tissue 3Health News:New model of ALS is based on human cells from autopsied tissue 4Health News:Alzheimer's Harder to Detect in the Very Old 2
Inquire...
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Silicone Compression Mat, Bulk...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Medicine Products: